Cytosorbents Corp.
$0.3719
USD
Last updated on --.
24h volume326.64K
24h highest0.38140 USD
24h lowest0.31100 USD
24h Price movement+19.54%
CTSO recent prices
24 Hours
+19.54%+$0.0608
30 days
-11.18%-$0.0404
60 days
-25.17%-$0.108
90 days
-22.72%-$0.1047
Key data
Previous close0.31110 USD
Market cap23.25M USD
Volume326.64K
P/E ratio--
Dividend yield (TTM)0.00%
Dividend amount--
Next ex-dividend date--
Next payment date--
EPS diluted (TTM)-0.29000 USD
Net income (FY)-18.21M USD
Revenue (FY)37.22M USD
Last report dateAug 6, 2026
About Cytosorbents Corp.
HeadquartersPRINCETON
Employees (FY)129.00
Revenue per employee (FY)288.50K USD
Net income per employee (FY)-141.19K USD
Listed onNasdaq
CTSO conversion tables
 |  |
|---|---|
| 0.5 CTSO | 0.18595 USD |
| 1 CTSO | 0.3719 USD |
| 5 CTSO | 1.859 USD |
| 10 CTSO | 3.719 USD |
| |
|---|---|
| 0.5 USD | 1.344 CTSO |
| 1 USD | 2.688 CTSO |
| 5 USD | 13.44 CTSO |
| 10 USD | 26.88 CTSO |
More to explore
Trending stock
Trending stock PERP
Trending stock token
FAQ
CTSO is trading at $0.3719, +19.54% over the last 24 hours. Track live moves on the price chart at the top of this page.
The CTSO stock forecast depends on a mix of factors — broader market conditions, sector trends, and company-specific drivers like earnings, product cycles, and macro signals. CTSO is currently trading at $0.3719, +19.54% over the last 24 hours, which reflects how the market is pricing these factors today. For a longer-term outlook on CTSO price action, review the 30-day, 60-day, and 90-day performance shown above, monitor momentum across the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, and watch overall market sentiment. Stock forecasts and price predictions are inherently uncertain — always DYOR.
P/E ratio (Price-to-Earnings, trailing twelve months) measures how much investors pay per dollar of earnings over the last 12 months. CTSO's P/E ratio is currently -- — calculated by dividing its share price by its trailing 12-month earnings per share (EPS). A higher P/E suggests investors expect stronger future growth from CTSO; a lower P/E may indicate the stock is undervalued or that the market is pricing in a weaker outlook. P/E ratios are most useful when compared against CTSO's historical range and other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.
Cytosorbents Corp.'s market cap is currently 23.25M USD. Market cap is calculated as stock price × total shares outstanding.
Disclaimer
The social content on this page ("Content"), including but not limited to tweets and statistics provided by LunarCrush, is sourced from third parties and provided "as is" for informational purposes only. OKX does not guarantee the quality or accuracy of the Content, and the Content does not represent the views of OKX. It is not intended to provide (i) investment advice or recommendation; (ii) an offer or solicitation to buy, sell or hold digital assets; or (iii) financial, accounting, legal or tax advice. Digital assets, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. The price and performance of the digital assets are not guaranteed and may change without notice.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
OKX does not provide investment or asset recommendations. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition. Please consult your legal/tax/investment professional for questions about your specific circumstances. For further details, please refer to our Terms of Use and Risk Warning.
24h volume326.64K
24h highest0.38140 USD
24h lowest0.31100 USD
24h Price movement+19.54%
Start trade with CTSO Perpetual
Sign up to trade